Skip to content
Tenfell
Awarded contract
Published 06 Apr 2021

Supply of testing for SARS-CoV-2 antibody test

NHS Blood and Transplant · United Kingdom

Key facts

Contract value
£655,000
Awarded
30 Mar 2021
Contract starts
30 Mar 2020
Contract ends
31 Mar 2022
Procedure
Other - Modification Notice
Buyer type
Health

Awarded to

SupplierValue
PUBLIC HEALTH ENGLAND£275,000

Description

NHS Blood and Transplant (NHSBT) are leading the Convalescent Plasma programme to explore the efficacy of donated plasma in the treatment of severe COVID-19 disease. Plasma will be donated by individuals who have recovered from COVID-19 disease and those plasma units with a sufficiently high level of antibody will be used as a treatment. Public Health England (PHE) will be carrying out Testing on the Materials on behalf of NHSBT. This will involve a SARS-CoV-2 IgG antibody Testing service (using a CE-marked assay) to NHSBT to enable the identification of convalescent plasma donations with sufficient level of antibody.

Duration extended from 31st March 2021 to 31st March 2022 to allow for testing of c. 7000 research samples from the RECOVERY clinical trial.

Additional information: Total value of original VEAT notice and this Modification notice is £380,000

Categories (CPV)

Similar open tenders

About NHS Blood and Transplant

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.